π€ Drug Discovery - Advanced Insights Episode 3
This article announces the recording of Episode 3 of Season 2 of Advanced Insights, featuring Abscibio's CEO and AMD's CTO discussing advancements in drug discovery.
Key Points:
β’ Behind-the-scenes look at the recording.
β’ Collaboration between Abscibio and AMD.
β’ Focus on future of drug discovery.
π Resources:
β’ Abscibio β - Biopharmaceutical company
β’ AMD β - Semiconductor company
β’ Sean McClain β - Abscibio CEO
Image
π€ Generative AI - Revolutionizing Drug Discovery
This article announces a presentation on how generative AI is transforming drug discovery at Bio-IT World.
Key Points:
β’ Presentation by Insilico Medicine's VP.
β’ Focus on Generative AI applications.
β’ Exploration of AI's impact on drug development.
π Resources:
β’ Insilico Medicine β - AI-driven drug discovery company
Image
π€ Longevity - Rejuve Longevity App Launch
This article announces the launch of the Rejuve Longevity App, emphasizing user contribution to scientific advancement and personal health benefits.
Key Points:
β’ App allows users to contribute to science.
β’ Focus on user health data contribution.
β’ Direct benefit for users and science.
π Resources:
β’ Rejuve AI β - AI for longevity
β’ SingularityNET β - Decentralized AI platform
β’ Ben Goertzel β - Co-founder of Rejuve AI & CEO of SingularityNET
Image
π€ Oncology - Top 5 Heme-Onc Trials for March 2025
This article highlights Larvol CLIN's presentation of the top 5 heme-oncology trials for March 2025, curated by leading oncologists.
Key Points:
β’ Top 5 trials selected by oncology experts.
β’ Overview of leading heme-oncology research.
β’ Insights into current clinical trials.
π Resources:
β’ Larvol CLIN β - Clinical trial information platform
Image
π€ Brain-Computer Interfaces - Synchron vs. Neuralink
This article compares Synchron and Neuralink's progress in brain-computer interfaces, highlighting Synchron's advancement in FDA trials and global IP.
Key Points:
β’ Synchron's lead in FDA trials and IP.
β’ Contrast between Synchron and Neuralink's strategies.
β’ Discussion of investment strategies in the field.
π Resources:
β’ Synchron β - Brain-computer interface company
β’ Neuralink β - Brain-computer interface company
β’ Nvidia β - Partner of Synchron
Image
π‘ Consciousness - Unified Conscious Field Theory
This article announces a new white paper on the Unified Conscious Field Theory (UCFT), uniting science and spirituality.
Key Points:
β’ Introduction of UCFT theory.
β’ Integration of science and spirituality.
β’ Publication in The Journal of Applied Magic.
π Resources:
β’ Hyperstition β - Publisher of UCFT white paper
Image
π Oncology - Tempus Hub's Comprehensive Therapy Selection
This article announces Comprehensive Therapy Selection (CTS) in Tempus Hub, designed to streamline cancer testing and prevent missed critical tests.
Key Points:
β’ Streamlined cancer testing ordering.
β’ Patient-specific test selection.
β’ Prevention of missed critical tests.
π Resources:
β’ Tempus β - AI-driven precision medicine company
Image
π€ ALS Clinical Trial - Unlearn AI Partnership
This article announces a partnership between Trace Neuroscience and Unlearn AI to optimize an ALS clinical trial using Unlearn AI's Digital Twin Generator.
Key Points:
β’ Partnership for ALS clinical trial optimization.
β’ Utilization of Unlearn AI's Digital Twin Generator.
β’ Improved planning for Phase 1/2 clinical trial.
π Resources:
β’ Unlearn AI β - AI for clinical trial optimization
β’ Trace Neuroscience β - Neuroscience company
β’ Eric Green β - CEO of Trace Neuroscience
Image
π‘ Allergy Relief - Rocket Doctor
This article promotes Rocket Doctor, a telehealth platform connecting users with physicians and allergy specialists for allergy relief.
Key Points:
β’ Provides access to physicians and specialists.
β’ Offers solutions for allergy symptoms.
β’ Convenient telehealth platform for allergy relief.
π Resources:
β’ Rocket Doctor β - Telehealth platform
Image
β¨ Cancer Diagnostics - Ibex MedAx User Meeting
This article summarizes the 2025 Ibex MedAx Insiders User Meeting in Boston, highlighting the company's vision for AI in cancer diagnostics.
Key Points:
β’ Successful user meeting with global attendance.
β’ Shared vision for AI in cancer diagnostics.
β’ Highlighted Ibex MedAx's AI solutions.
π Resources:
β’ Ibex MedAx β - AI for cancer diagnostics
Image
βοΈ Support
If you liked reading this report, please star βοΈ this repository and follow me on Github β, π (previously known as Twitter) β to help others discover these resources and regular updates.
